The US Food and Drug Administration's (FDA) Bad Ad Program, an effort to encourage physicians and other healthcare providers to report "suspected untruthful or misleading prescription drug promotion," ...

On September 9, 2025, the U.S. Food and Drug Administration (“FDA”) Office of Prescription Drug Promotion (“OPDP”) issued numerous untitled letters as part of the agency’s wider attack on direct to ...

The FDA is apparently not charmed by the mischievous “Lipid Lurkers” in an Esperion Therapeutics commercial for cholesterol-lowering drug Nexlizet. An untitled letter (PDF) from the agency, dated Dec.

In the wake of President Donald Trump’s recent executive action directing the Department of Health and Human Services and the Food and Drug Administration to “rein in misleading” direct-to-consumer ...

The US Food and Drug Administration (FDA) commissioner Martin Makary has described the current state of direct-to-consumer pharmaceutical advertising as a “public health crisis” in the US, citing lax ...

Please provide your email address to receive an email when new articles are posted on . The FDA said it will send letters to pharmaceutical companies asking for the removal of “misleading” drug ads.

Specifically, the agency took Esperion to task for two violations: false or misleading exclusivity claims and visual distractions from product safety warnings. Esperion’s Lipid Lurkers educational ...

For the first time, federal health officials are taking aim at telehealth companies promoting unofficial versions of prescription drugs - including popular weight loss medications - as part of the ...

WASHINGTON — For the first time, federal health officials are taking aim at telehealth companies promoting unofficial versions of prescription drugs — including popular weight loss medications — as ...

The FDA has scolded Pfizer over Facebook ads for the cancer drug Adcetris, accusing the Big Pharma of failing to adequately communicate the indication, contraindications and risks. Continuing a wave ...

This article first appeared in the newsletter Your Local Epidemiologist. Pharmaceutical ads in the United States are annoying. Absurd. And almost uniquely American. In fact, only one other high-income ...